Categories: HospitalsNews

Harrington Discovery Institute Opens Call for 2026 Harrington Scholar-Innovator Award

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Unique program for physician-scientists to advance promising discoveries into medicines

CLEVELAND, April 16, 2025 /PRNewswire/ — Harrington Discovery Institute at University Hospitals is now accepting Letters of Intent for the 2026 Harrington Scholar-Innovator Award for physician-scientists. The award offers successful applicants multiple opportunities for funding in addition to expertise from pharma-experienced leaders with a track record of bringing drugs to market. Intellectual property rights are retained by the award recipient and/or their institution. Up to 12 Scholar-Innovators will be selected to receive:

  • $100,000 guaranteed grant award;
  • Drug and business development support from Harrington’s Therapeutics Development Center advisors;  
  • Opportunity to compete for acceleration funds up to $300,000;
  • Opportunity to qualify for investment funds typically up to $2M.

The call is open to physician-scientists at accredited academic medical centers, research institutions and universities in the United States and Canada. Applicants must have a doctorate in medicine. Selection criteria include innovation, creativity and the potential for clinical impact. Award recipients will be selected by Harrington Discovery Institute’s Scientific Advisory Board and announced in April 2026.

The deadline to submit a brief Letter of Intent is June 4, 2025. The full application deadline, for those invited to submit, is August 4, 2025.

Learn more and apply to the 2026 Scholar-Innovator Award:
HarringtonDiscovery.org/Scholar-Innovators

View original content:https://www.prnewswire.com/news-releases/harrington-discovery-institute-opens-call-for-2026-harrington-scholar-innovator-award-302429952.html

SOURCE Harrington Discovery Institute

Staff

Recent Posts

LEGACY EDUCATION INC. ACHIEVES RECORD Q3 WITH 50% REVENUE GROWTH AND SURPASSES 3,000 ENROLLED STUDENTS

LANCASTER, Calif., May 15, 2025 /PRNewswire/ -- Legacy Education Inc. (NYSE American: LGCY), a leading…

5 hours ago

BrainStorm Cell Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update

Conference call and webcast rescheduled for 8:30 a.m. Eastern Time on Monday, May 19 NEW…

5 hours ago

MediKarma Aligns with CMS National Preventive Health Strategy Through AI-Driven, Prevention-First Implementation Infrastructure

SAN FRANCISCO, May 15, 2025 /PRNewswire/ -- MediKarma, a digital health company specializing in AI-powered…

5 hours ago

Dentegrate AI Powers Growth for 220+ Dental Practices, Doubling New Patient Acquisition

BOSTON, May 15, 2025 /PRNewswire/ -- Dentegrate AI is revolutionizing dental practice growth, with over…

5 hours ago

Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Clinical trial advances for INSTASYL siRNA lead product candidate PH-762 4th Cohort enrolling and treating…

6 hours ago

cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter

Successfully Completes Capital Structure Reset with Series A Preferred ConversionCharlotte, North Carolina--(Newsfile Corp. - May…

6 hours ago